Drugs for esophageal cancer

summary

Modern traditional Chinese medicine combined with surgery, radiotherapy and chemotherapy can increase efficiency, reduce toxicity and improve the cure rate. For patients in the middle and advanced stages who can't do surgery, radiotherapy and chemotherapy, using traditional Chinese medicine can control the disease, prolong life, improve the quality of life and realize "survival with tumor". So, let's take a look at the relevant knowledge about drugs for the treatment of esophageal cancer.

Drugs for esophageal cancer

Drug 1: epidermal growth factor receptor targeted therapy: epidermal growth factor receptor belongs to type I transmembrane tyrosine kinase growth factor receptor, which is the expression product of proto oncogene c-erbB-1 and can regulate cell growth, differentiation, angiogenesis and apoptosis. Its signaling pathway is closely related to the growth, invasion and metastasis of malignant tumors. EGFR overexpression is found in most epithelial tumors, and 40% - 80% of esophageal cancer patients are accompanied by EGFR overexpression.

Drug 2: tumor angiogenesis inhibitor: vascular endothelial growth factor (VEGF) and its receptor (VEGFR-1) play an important role in inducing angiogenesis. Anti angiogenesis therapy may become another potential therapeutic target for esophageal cancer.

Drug 3: cell cycle inhibitors cyclin dependent kinase inhibitors: cell cycle inhibitors cyclin dependent kinases (CDKs) are a family of proteins that regulate cell cycle. In tumor tissues, CDKs "over activation" leads to uncontrolled cell proliferation.

matters needing attention

Esophageal cancer is easy to make the tube become narrow, so patients will be very obvious to some cold food stimulation, prone to side effects, also prone to nausea and vomiting, pain and distension and numbness and other feelings, easy to digest as the main principle, the best or liquid food.